切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2010, Vol. 06 ›› Issue (01) : 44 -46. doi: 10.3877/cma.j.issn.1673-5250.2010.01.115

论著

中、晚期宫颈癌三维适形放疗联合介入化疗的疗效分析
周路, 覃强, 刘星   
  1. 528333 佛山,佛山市顺德区中医院
  • 出版日期:2010-02-01

Efficacy of Three-Dimensional Conformal Radiation Therapy Combined With Interventional Chemotherapy for Intermediate and Advanced Cervical Cancer

Lu ZHOU, Qiang QIN, Xing LIU   

  1. Foshan Hospital of Integrated Traditional Medicine, Foshan 528333, Guangdong Province, China
  • Published:2010-02-01
引用本文:

周路, 覃强, 刘星. 中、晚期宫颈癌三维适形放疗联合介入化疗的疗效分析[J]. 中华妇幼临床医学杂志(电子版), 2010, 06(01): 44-46.

Lu ZHOU, Qiang QIN, Xing LIU. Efficacy of Three-Dimensional Conformal Radiation Therapy Combined With Interventional Chemotherapy for Intermediate and Advanced Cervical Cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2010, 06(01): 44-46.

目的

探讨三维适形放射治疗(three-dimensional conformal radiation therapy, 3DCRT)+介入化疗治疗中、晚期宫颈癌的疗效。

方法

2006年5月至2007年5月选取80例在本院确诊为ⅡB~Ⅲ期的宫颈癌患者为研究对象,将其随机分为试验组(n=40,三维适形放疗+介入化疗)和对照组(n=40,三维适形放疗+静脉化疗) (研究遵循程序符合本院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得患者知情同意,并与之签署临床研究知情同意书),比较两组疗效、不良反应率和程度,并随访2年以上。

结果

试验组患者完全缓解(complete remission, CR)率、2年生存率均高于对照组(85.0% vs. 77.5%, 87.5% vs. 75.0%),两组比较,差异有显著意义(P<0.05);骨髓抑制率、胃肠道系统不良反应率及严重程度明显低于对照组,两组比较,差异有显著意义(P<0.05);泌尿系统不良反应率两组比较,差异无显著意义(P=1.107)。

结论

三维适形放疗+介入化疗是治疗中、晚期宫颈癌的有效方法,不良反应程度轻,疗效高,临床上值得推广应用。

Objective

To study the efficacy of three-dimensional conformal radiation therapy(3DCRT) combined with interventional chemotherapy for intermediate and advanced cervical cancer.

Methods

From March 2006 to May 2007, 80 women patients with cervical cancer at ⅡB-Ⅲ stage were randomly divided into experimental group(n=40) which received three-dimensional conformal radiation therapy combined with interventional chemotherapy and control group(n=40) which received three-dimensional conformal radiation therapy combined with intravenous chemotherapy. Efficacy and side effects were compared between two groups, and follow-up more than 2 years. Informed consent was obtained from all participates.

Results

Complete remission(CR) rate and 2-year survival rate of experimental group were significantly higher than those of control group (85.0% vs. 77.5%, 87.5% vs. 75.0%) (P<0.05). Side effects of gastrointestinal tract and myelosuppression were less serious than those of control group(P<0.05). There had no significant differences in side effects of urinary system between two groups (P=1.107).

Conclusion

Three-dimensional conformal radiation therapy combined with interventional chemotherapy could improve the clinical efficacy with less side effects. It is an effective treatment for intermediate and advanced cervical cancer.

1 Qi HY, Zhang LY, Song JH. Clinical observation of the neoadjuvant chemotherapy on locally advanced cervical carcinoma stage IB2-ⅡB: An analysis of 34 cases[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2009, 5(1): 73-75.[齐红岩,张林燕,宋静慧.局部晚期宫颈癌ⅠB2至ⅢB期34例全身新辅助化疗的术前疗效观察[J/CD].中华妇幼临床医学杂志:电子版,2009, 5(1): 73-75.]
2 Liu P, Liu YL. Prospective cohort research on cervical carcinoma screening of thinprep cytological test combined with human papilloma virus hybrid capture[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2009, 5(1): 18-22.[刘萍,刘岩丽.液基薄层宫颈刷片细胞学检查结合二代杂交捕获法人乳头病毒筛查宫颈癌的前瞻性队列研究[J/CD].中华妇幼临床医学杂志:电子版,2009,5(1):18-22.]
3 del Campo JM, Prat A, Gil-Moreno A, et al. Update on novel therapeutic agents for cervical cancer[J]. Gynecol Oncol, 2008, 110(3 Suppl 2):S72-76.
4 Reimer D, Sztankay A, Steppan I, et al. Cervical cancer associated with genital prolapse——A brief review of the literature and long-term results of successful treatment with radiochemotherapy and surgery in a very frail patient[J]. Eur J Gynaecol Oncol, 2008, 29(3): 272-275.
5 Chemoradiotherapy for Cervical Cancer meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials[J]. J Clin Oncol, 2008, 26(35):5802-5812.
6 Moore DH. Chemotherapy for advanced, recurrent, and metastatic cervical cancer[J]. J Natl Compr Canc Netw, 2008, 6(1): 53-57.
7 Taylor A, Powell ME. Conformal and intensity-modulated radiotherapy for cervical cancer[J]. Clin Oncol (R Coll Radiol), 2008, 20(6): 417-425.
8 Tzioras S, Pavlidis N, Paraskevaidis E, et al. Effects of different chemotherapy regimens on survival for advanced cervical cancer: Systematic review and meta-analysis[J]. Cancer Treat Rev, 2007, 33(1): 24-38.
No related articles found!
阅读次数
全文


摘要